Portfolia backs high opportunity companies with the right teams, the right products, at the right time for the most optimal returns. Thank you Fast Company for featuring 3 of our portfolio companies in your article on 'The most promising health and wellness trends for 2019'.
"'The chance of getting pregnant in a single month is only about 20 percent in a healthy couple,’ says Dr. Jennifer Conti, clinical assistant professor of obstetrics and gynecology at Stanford University School of Medicine. ‘Even when they're doing everything right.’ ’Infertility is often seen as a woman's problem,’ says Dr. Michael Eisenberg, associate professor of urology at Stanford University. ‘But only about one- third of infertility cases are women, 30 percent are men and 30 percent of the time it's both.’”
Portfolia backed company Trak is directly addressing this problem through their male fertility test. To learn more about Trak’s fertility test check out this article and sign up for our next FemTech call to learn about innovative fertility technology: https://bit.ly/2Mt9d0x
People often ask us how to evaluate the companies that we come across. Below are the categories we use to evaluate incoming companies, or opportunities, for potential investment. If you know of any early-stage companies that meet these qualities (or have friends that do), send them our way via our referral page. For a deeper dive, sign up to join us on our investment platform. Happy deal hunting!
One of our favorite questions to ask of our entrepreneurial start-ups is “Why Now?”
Portfolia-backed company, 4Degrees, which just secured additional funding (Congrats!), uses artificial intelligence (AI) to improve your competitive advantage when managing professional relationships. Given that Steve Levine from Axios just reported that a recent McKinsey report shows early AI adopters may gain an “insurmountable advantage” and that “companies failing to quickly embrace AI to improve growth, risk falling further and further behind” we think that’s a good idea -- and a timely one at that.
Collette Courtion, Founder and CEO of Portfolia-backed FemTech company JoyLux, shares how they're redefining women's sexual wellness in Fast Company's This Vaginal Device Pomises to Fix Women's Sex Lives. "Women are becoming far much more empowered to embrace their health in all parts of their life,” says Courtion. Joylux found that 50% of respondents reported bladder leakage issues, and when asked if they were interested in a home solution, a whopping 95% answered yes. “That tells me that it’s an underserved market,” says Courtion.
While Femtech is predicted to be a $50B industry by 2025, only 1.4% of venture capital is invested in it. Sign up to learn more about our open FemTech Fund.